Cargando…
Metastatic Lesion of the Tibia from Renal Cell Carcinoma
INTRODUCTION: Renal cell carcinoma is responsible for 3% of all cancers, with the highest incidence occurring in Western countries. Additionally, in patients with osseous metastasis, only 3% occur within the tibia. Rarely, a patient presents with a primary complaint of lower limb pain in advanced me...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349284/ https://www.ncbi.nlm.nih.gov/pubmed/34373797 http://dx.doi.org/10.1155/2021/2428820 |
_version_ | 1783735536078290944 |
---|---|
author | Młodożeniec, Piotr Balawender, Krzysztof Zasadny, Mateusz |
author_facet | Młodożeniec, Piotr Balawender, Krzysztof Zasadny, Mateusz |
author_sort | Młodożeniec, Piotr |
collection | PubMed |
description | INTRODUCTION: Renal cell carcinoma is responsible for 3% of all cancers, with the highest incidence occurring in Western countries. Additionally, in patients with osseous metastasis, only 3% occur within the tibia. Rarely, a patient presents with a primary complaint of lower limb pain in advanced metastatic renal cell carcinoma. Case Presentation. The patient arrived at the emergency department with a primary complaint of left ankle pain. Ankle X-rays demonstrated a lytic lesion involving the medial malleolus with possible metastatic disease. CT scan confirmed a tumor within the right kidney. The patient was treated with a laparoscopic radical nephrectomy with histopathologic confirmation of clear cell renal cell carcinoma. Biopsy was then performed of the tibial lesion, confirming metastatic clear cell renal cell carcinoma. The tibial lesion was treated with local radiotherapy, and because of the progression of the tibia lesion, a decision was made to amputate the leg. Additionally, the patient was enrolled to sunitinib treatment and was disease free at one year of follow-up. 13 months after diagnosis of cancer, she was suffering a major stroke of the brain that caused her to die. CONCLUSION: The treatment of patients with osseous metastases of renal cell cancer depends on the number of metastases, location of metastases, and overall health of the patient. We performed an overview of available literature and provided a summary regarding the use of cytoreductive nephrectomy, local therapy, target therapy, and bone-targeting agents in the treatment of metastatic renal cell cancer. |
format | Online Article Text |
id | pubmed-8349284 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-83492842021-08-08 Metastatic Lesion of the Tibia from Renal Cell Carcinoma Młodożeniec, Piotr Balawender, Krzysztof Zasadny, Mateusz Case Rep Oncol Med Case Report INTRODUCTION: Renal cell carcinoma is responsible for 3% of all cancers, with the highest incidence occurring in Western countries. Additionally, in patients with osseous metastasis, only 3% occur within the tibia. Rarely, a patient presents with a primary complaint of lower limb pain in advanced metastatic renal cell carcinoma. Case Presentation. The patient arrived at the emergency department with a primary complaint of left ankle pain. Ankle X-rays demonstrated a lytic lesion involving the medial malleolus with possible metastatic disease. CT scan confirmed a tumor within the right kidney. The patient was treated with a laparoscopic radical nephrectomy with histopathologic confirmation of clear cell renal cell carcinoma. Biopsy was then performed of the tibial lesion, confirming metastatic clear cell renal cell carcinoma. The tibial lesion was treated with local radiotherapy, and because of the progression of the tibia lesion, a decision was made to amputate the leg. Additionally, the patient was enrolled to sunitinib treatment and was disease free at one year of follow-up. 13 months after diagnosis of cancer, she was suffering a major stroke of the brain that caused her to die. CONCLUSION: The treatment of patients with osseous metastases of renal cell cancer depends on the number of metastases, location of metastases, and overall health of the patient. We performed an overview of available literature and provided a summary regarding the use of cytoreductive nephrectomy, local therapy, target therapy, and bone-targeting agents in the treatment of metastatic renal cell cancer. Hindawi 2021-07-30 /pmc/articles/PMC8349284/ /pubmed/34373797 http://dx.doi.org/10.1155/2021/2428820 Text en Copyright © 2021 Piotr Młodożeniec et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Młodożeniec, Piotr Balawender, Krzysztof Zasadny, Mateusz Metastatic Lesion of the Tibia from Renal Cell Carcinoma |
title | Metastatic Lesion of the Tibia from Renal Cell Carcinoma |
title_full | Metastatic Lesion of the Tibia from Renal Cell Carcinoma |
title_fullStr | Metastatic Lesion of the Tibia from Renal Cell Carcinoma |
title_full_unstemmed | Metastatic Lesion of the Tibia from Renal Cell Carcinoma |
title_short | Metastatic Lesion of the Tibia from Renal Cell Carcinoma |
title_sort | metastatic lesion of the tibia from renal cell carcinoma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349284/ https://www.ncbi.nlm.nih.gov/pubmed/34373797 http://dx.doi.org/10.1155/2021/2428820 |
work_keys_str_mv | AT młodozeniecpiotr metastaticlesionofthetibiafromrenalcellcarcinoma AT balawenderkrzysztof metastaticlesionofthetibiafromrenalcellcarcinoma AT zasadnymateusz metastaticlesionofthetibiafromrenalcellcarcinoma |